PK/PD Laboratory -
Hands-on PK evaluation |
"PK/PD
Laboratory - Hands-on PK evaluation" Enjoy our offer to "BRING
YOUR OWN DATA"
You
may submit your data via email to bulitta@ibmp.osn.de
. Please indicate in the email text, when you would like to discuss the
analysis of your data at the PK/PD Laboratory. For sophisticated PK/PD
analyses you may also discuss strategies with the experts. Thus, we could
reserve time slots for you. We would very much appreciate submission at
your earliest convenience. Submissions will be reserved on a "first
come first served basis". Please note, Pharsight offers a Pharsight Academic Licensing (PAL) program for academic, research, and educational use of Pharsight products at selected Academic Institutions. This program allows academic institutions the use of Pharsight software products free of charge. License conditions can be found under this link.
The
following Pharsight software products will be presented by senior experts
at the PK/PD Laboratory: |
WinNonlin is a PK/PD software that provides a complete solution with analysis, statistics, modeling, and visualization tools included in one package. Its intuitive interface and flexible framework facilitate the use of this powerful application. WinNonlin is a software that can be applied for high-throughput pharmacokinetic analysis. However, any kind of linear and nonlinear regression can be performed with WinNonlin. It is no way limited to first order differential equation systems. Its Table generator and Graph Wizard as in-built features allow extremely fast overviews even for large datasets. After
PK/PD evaluation, statistical analyses (including average and individual
bioequivalence, ANOVA and ANCOVA) can be performed by non-professional
statisticians. It may take only minutes from starting with concentration
time raw data to the final statistical analysis (even for beginners). |
Conducting
population PK/PD analysis is particularly important in later phases of
clinical trials. Population PK/PD modeling can directly include subject
specific factors like sex, ethnic group, age, renal function, weight,
etc. in the analysis. This allows subgroup analysis and provides a basis
for understanding any differences that may exist. |
Before
starting each actual clinical trial, the Pharsight Trial Simulator provides
In
the late Phase 2 and Phase 3 trials, use of the Pharsight Trial Simulator
may eliminate costly missteps and accelerates progress along the path
to approval and marketing. |